Literature DB >> 7542529

Up-regulation of a chondroitin sulphate epitope during regeneration of mouse sciatic nerve: evidence that the immunoreactive molecules are related to the chondroitin sulphate proteoglycans decorin and versican.

K H Braunewell1, R Martini, R LeBaron, H Kresse, A Faissner, B Schmitz, M Schachner.   

Abstract

After transection of adult mouse sciatic nerve, the expression of a chondroitin sulphate epitope recognized by the monoclonal antibody 473-HD (mAb 473-HD) was found to be up-regulated. The epitope was localized immunocytochemically mainly in Schwann cell basal laminae and, more weakly, also in the endoneurium. In cultures of mouse dorsal root ganglion cells, Schwann cells expressed high levels but fibroblasts only low levels of the epitope. To identify the molecule(s) carrying this chondroitin sulphate epitope, human sciatic nerves were extracted with phosphate-buffered saline and shown to contain two chondroitin sulphate proteoglycans of apparent molecular weights of 130 and 900 kDa. The 900 kDa and, more weakly, the 130 kDa proteoglycan were reactive with mAb 473-HD, which was found to recognize chondroitin-6-sulphate as epitope. Following chondroitinase ABC treatment of the 130 kDa proteoglycan, a core protein of approximately 45 kDa was seen and shown to react with polyclonal antibodies against the chondroitin-dermatan sulphate proteoglycan decorin from human fibroblasts. Chondroitinase ABC treatment of the 900 kDa proteoglycan yielded a core protein with a molecular weight of approximately 400 kDa that was recognized by polyclonal antibodies against recombinantly expressed fusion proteins from human versican. After transection of adult mouse sciatic nerves, the distal nerve stumps showed up-regulation of the chondroitin-6-sulphate epitope of the 900 kDa proteoglycan, whereas the core protein of this proteoglycan did not show any detectable change in the level of expression. In contrast, the core protein of the 130 kDa proteoglycan was up-regulated in expression. These observations suggest that versican- and decorin-like molecules may contribute to successful regeneration in the peripheral nervous system of mammals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542529     DOI: 10.1111/j.1460-9568.1995.tb00682.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  12 in total

1.  The effects of proteoglycan surface patterning on neuronal pathfinding.

Authors:  V Hlady; G Hodgkinson
Journal:  Materwiss Werksttech       Date:  2007-12-01       Impact factor: 0.854

2.  Chondroitinase applied to peripheral nerve repair averts retrograde axonal regeneration.

Authors:  James B Graham; Debbie Neubauer; Qing-Shan Xue; David Muir
Journal:  Exp Neurol       Date:  2006-09-12       Impact factor: 5.330

3.  The differential influence of colocalized and segregated dual protein signals on neurite outgrowth on surfaces.

Authors:  Gerald N Hodgkinson; Patrick A Tresco; Vladimir Hlady
Journal:  Biomaterials       Date:  2007-02-07       Impact factor: 12.479

4.  Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration.

Authors:  A T Dailey; A M Avellino; L Benthem; J Silver; M Kliot
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

5.  Repellent guidance of regenerating optic axons by chondroitin sulfate glycosaminoglycans in zebrafish.

Authors:  Catherina G Becker; Thomas Becker
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 6.  The neuroimmunology of degeneration and regeneration in the peripheral nervous system.

Authors:  A DeFrancesco-Lisowitz; J A Lindborg; J P Niemi; R E Zigmond
Journal:  Neuroscience       Date:  2014-09-19       Impact factor: 3.590

7.  Neuritic outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein (GFAP) mRNA in injured neuron-astrocyte cocultures.

Authors:  T Lefrançois; C Fages; M Peschanski; M Tardy
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

8.  An axon regeneration signature in a Charcot-Marie-Tooth disease type 2 patient.

Authors:  Francesca Cavalcanti; Thomas Kidd; Alessandra Patitucci; Paola Valentino; Francesco Bono; Rita Nisticò; Aldo Quattrone
Journal:  J Neurogenet       Date:  2009       Impact factor: 1.250

9.  Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment.

Authors:  M Pérez; F Wandosell; C Colaço; J Avila
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

10.  Patterns of chondroitin sulfate immunoreactivity in the developing tectum reflect regional differences in glycosaminoglycan biosynthesis.

Authors:  D Hoffman-Kim; A D Lander; S Jhaveri
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.